Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Timothy J. Wilkin

Division of Infectious Diseases

Weill Medical College of Cornell University

New York

New York 10065; email:

[email]@med.cornell.edu

Name/email consistency: high

[Claim this account]

Affiliations

Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York 10065; email:. 2007 - 2012
Cornell HIV Clinical Trials Unit, Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, Box 566, USA. ;. 2003 - 2008

References

CCR5 Antagonism in HIV Infection: Current Concepts and Future Opportunities. Wilkin, T.J., Gulick, R.M. Annu. Rev. Med. (2012) [Pubmed]
The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patients. Wilkin, T.J., Ribaudo, H.R., Tenorio, A.R., Gulick, R.M. HIV. Clin. Trials (2010) [Pubmed]
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients. Wilkin, T.J., Su, Z., Krambrink, A., Long, J., Greaves, W., Gross, R., Hughes, M.D., Flexner, C., Skolnik, P.R., Coakley, E., Godfrey, C., Hirsch, M., Kuritzkes, D.R., Gulick, R.M. J. Acquir. Immune Defic. Syndr. (2010) [Pubmed]
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. Wilkin, T.J., McKinnon, J.E., DiRienzo, A.G., Mollan, K., Fletcher, C.V., Margolis, D.M., Bastow, B., Thal, G., Woodward, W., Godfrey, C., Wiegand, A., Maldarelli, F., Palmer, S., Coffin, J.M., Mellors, J.W., Swindells, S. J. Infect. Dis. (2009) [Pubmed]
When to start antiretroviral therapy?. Wilkin, T.J., Gulick, R.M. Clin. Infect. Dis. (2008) [Pubmed]
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Wilkin, T.J., Su, Z., Kuritzkes, D.R., Hughes, M., Flexner, C., Gross, R., Coakley, E., Greaves, W., Godfrey, C., Skolnik, P.R., Timpone, J., Rodriguez, B., Gulick, R.M. Clin. Infect. Dis. (2007) [Pubmed]
Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. Wilkin, T.J., Palmer, S., Brudney, K.F., Chiasson, M.A., Wright, T.C. J. Infect. Dis. (2004) [Pubmed]
Antiretroviral therapy: when and what to start-- an American perspective. Wilkin, T.J., Gulick, R.M. Current. Hiv/aids. Reports (2004) [Pubmed]
Antiretroviral Therapy: When and What to Start-- An American Perspective. Wilkin, T.J., Gulick, R.M. Curr. Infect. Dis. Rep (2003) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.